Articles from Edison Scientific

Edison Scientific announced an agreement to deploy the Edison AI Platform and Kosmos, Edison's AI scientist, across Pfizer’s biopharmaceutical research and development pipeline. The collaboration brings together Edison’s industry-leading AI capabilities with Pfizer’s scientific expertise and robust repositories of data across oncology, internal medicine, immunology, and more. Kosmos will access Pfizer’s data to support Pfizer’s scientists, inform critical decisions in R&D, and help accelerate the discovery of potential new medicines.

Edison Scientific is pleased to announce that it has signed a subscription agreement with Springer Nature that will bring trusted licensed content from 60 specialist journals across Springer Nature's Nature Portfolio into Edison’s AI scientist, Kosmos.